Healthcare Industry News: PET scan
News Release - January 20, 2010
First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
SAN DIEGO, Jan. 20 -- (Healthcare Sales & Marketing Network) -- First Coast Oncology in Jacksonville, Florida has significantly enhanced its ability to treat breast cancer with the addition of a Naviscan PEM (Positron Emission Mammography) scanner. The facility will be among the first in the nation to use both a PEM scanner and the AccuBoost image guided breast irradiation procedure to optimize their therapy treatment.AccuBoost is a technique for whole breast irradiation that is designed to target and deliver a boost dose accurately and reliably to the lumpectomy cavity margin. With PEM's three-dimensional metabolic perspective, physicians will be able to better visualize the region of interest prior to deploying the AccuBoost system, which lowers dose to healthy tissue as radiation is focused on the intended target sparing exposure to the heart, lungs and the uninvolved breast.
First Coast Oncology has three locations and focuses on providing the latest cancer treatment options available. "For more than 10 years, First Coast Oncology has provided the highest level of care to the women in Northeast Florida and Southeast Georgia who have been diagnosed with breast cancer," said Scot Ackerman, M.D., Medical Director of First Coast Oncology. "The acquisition of the Naviscan PEM scanner demonstrates First Coast Oncology's commitment to securing the latest technology to detect and treat breast cancer as well as being able to assess response to therapy. I expect that PEM will prove indispensable in the effective management of breast cancer for both our patients and referring physicians."
The Naviscan PEM scanner uses PET (Positron Emission Tomography) technology to produce high-resolution tomographic images at 2 millimeter resolution, allowing physicians to visualize breast tumors about the size of a grain of rice. The scanner is the size of a mammography unit and consists of two high-resolution detector heads which are placed in close proximity to the breast. Compared to the higher-force compression necessary for mammography, the Naviscan PEM scanner uses gentle breast immobilization.
About Naviscan, Inc.
Naviscan, Inc., founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging, guide radiological and surgical procedures and advance new clinical therapies. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. as well as utilized in clinical research studies, funded in part by the National Institutes of Health. The Company is headquartered in San Diego, California and is the first company to obtain FDA clearance of a high-resolution PET scanner designed to image small body parts. For more information, call 1.858.587.3641 or visit www.naviscan.com
About First Coast Oncology
First Coast Oncology's staff consists of board-certified radiation oncologists and medical physicists, certified medical dosimetrists, a nuclear medicine technologist, oncology certified nurses, oncology social workers, and radiation therapists.
First Coast Oncology offers convenient care at their state-of-the-art facilities throughout Northeast Florida. Their locations at Mandarin, Baptist Medical Center – Nassau and St. Vincent's Medical Center, offer the most advanced medical equipment and technology.
First Coast Oncology's practice is dedicated to advancing the understanding, treatment, and prevention of cancer through research, advocacy, and community service. For more information, visit www.firstcoastoncology.com
Source: Naviscan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
